Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-EN Version v13-EN
Language English English
Date Updated 2020-05-14 2020-02-07
Drug Identification Number 00851973 00851973
Brand name TEVA-TAMOXIFEN TEVA-TAMOXIFEN
Common or Proper name TAMOXIFEN TAMOXIFEN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TAMOXIFEN TAMOXIFEN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30UD 30UD
ATC code L02BA L02BA
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-09-18 2019-09-18
Estimated end date 2020-05-15 2020-03-15
Actual end date 2020-05-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments We are allocating to cover our share of the market out to the full recovery in Mid-May 2020. We are allocating to the end of Feb to cover approx. 30% of market demand.
Health Canada comments